Paasa Logo
Orchestra BioMed Holdings, Inc. logo
OBIONASDAQMarket closedOpens 9:30am ET

Orchestra BioMed Holdings, Inc.

$5.89Last updated
-$0.06 (1.01%)Past day
Timezone

Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) is trading at $5.89, about ₹565 at today's USD/INR rate, as of 28 Sep 2026, 4:00 PM ET, down 1.01% today. Indian residents can buy Orchestra BioMed from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$5.95
Previous close:$5.95
Volume:177.45K

Today's low

$5.84

Today's high

$5.95

52 week low

$2.40

52 week high

$6.48

OBIO opened at $5.95, closed previously at $5.95, and has traded between $2.40 and $6.48 over the past 52 weeks.

About

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.

Country
US
CEO
David Hochman
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
86
Sector
Healthcare
IPO date
04/08/2020

Key statistics

Avg. volume

342.67K

Market cap

$352.70M

P/E Ratio

-5.95

Price-to-sales ratio

11.03

Enterprise value

$402.99M

Free cash flow yield

-16.76%

Debt-to-equity ratio

2.41

Return on equity

-125.93%

ROIC

-56.28%

Beta

0.53

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$33.48M

Earnings per share

-$1.11

Free cash flow

-$49.45M

Net profit margin

-184.60%

Gross margin

99.32%

EBITDA

-$51.23M

Revenue growth

1169.22%

Similar securities

This is not an investment recommendation

How to buy Orchestra BioMed from India

Indian residents can buy Orchestra BioMed shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Orchestra BioMed and place an order

    Find Orchestra BioMed by name or by its ticker, OBIO, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Orchestra BioMed trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Orchestra BioMed position in USD and INR. Orchestra BioMed pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Orchestra BioMed from India

Trading and taxes when buying Orchestra BioMed from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneOrchestra BioMed does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Orchestra BioMed stock?

Yes. Orchestra BioMed (OBIO) has been listed on NASDAQ since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Orchestra BioMed share cost in rupees?

One Orchestra BioMed share is $5.89 — about ₹565 at a USD/INR rate of 95.93 on 27 Sep 2026. Both the Orchestra BioMed price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Orchestra BioMed from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Orchestra BioMed?

Yes. One Orchestra BioMed share is $5.89, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Orchestra BioMed.

How are gains on Orchestra BioMed shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Orchestra BioMed price. Paasa issues a capital-gains statement for your return.

Does Orchestra BioMed pay a dividend?

No. Orchestra BioMed does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Orchestra BioMed from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Orchestra BioMed shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Orchestra BioMed shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Orchestra BioMed holding, its cost and its closing value.

How do I sell Orchestra BioMed and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.